Wells Fargo Maintains Equal-Weight on Amgen, Raises Price Target to $460
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $430 to $460.
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $430 to $460.